Joseph H. Oved

562 total citations
34 papers, 185 citations indexed

About

Joseph H. Oved is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Joseph H. Oved has authored 34 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 19 papers in Immunology and 11 papers in Oncology. Recurrent topics in Joseph H. Oved's work include Hematopoietic Stem Cell Transplantation (12 papers), Immunodeficiency and Autoimmune Disorders (10 papers) and CAR-T cell therapy research (5 papers). Joseph H. Oved is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Immunodeficiency and Autoimmune Disorders (10 papers) and CAR-T cell therapy research (5 papers). Joseph H. Oved collaborates with scholars based in United States, Australia and United Kingdom. Joseph H. Oved's co-authors include David M. Barrett, David T. Teachey, James B. Bussel, Mortimer Poncz, Konrad J. Karczewski, Michele P. Lambert, M. Anna Kowalska, Susan E. Prockop, Carol Shoshkes Reiss and Timothy S. Olson and has published in prestigious journals such as Blood, Cell stem cell and Immunological Reviews.

In The Last Decade

Joseph H. Oved

24 papers receiving 183 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph H. Oved United States 8 71 52 48 33 24 34 185
Eva Wagner-Drouet Germany 8 92 1.3× 47 0.9× 81 1.7× 55 1.7× 13 0.5× 28 175
Verena Wais Germany 8 55 0.8× 25 0.5× 48 1.0× 46 1.4× 51 2.1× 21 193
Patric Teodorescu Romania 10 90 1.3× 33 0.6× 44 0.9× 64 1.9× 42 1.8× 30 186
Daphne N. Pariser United States 5 52 0.7× 42 0.8× 26 0.5× 32 1.0× 8 0.3× 6 144
Jadee Neff United States 7 24 0.3× 55 1.1× 29 0.6× 48 1.5× 34 1.4× 25 159
Katarzyna Aleksandra Jalowiec Switzerland 7 66 0.9× 51 1.0× 50 1.0× 15 0.5× 38 1.6× 17 146
Tobias Wertheimer Germany 6 38 0.5× 68 1.3× 45 0.9× 10 0.3× 6 0.3× 15 144
Jacinth Joseph United States 6 64 0.9× 13 0.3× 65 1.4× 52 1.6× 60 2.5× 16 179
Stephen DeWall United States 7 31 0.4× 93 1.8× 52 1.1× 124 3.8× 8 0.3× 12 227
Oscar Borsani Italy 7 68 1.0× 25 0.5× 35 0.7× 45 1.4× 27 1.1× 20 211

Countries citing papers authored by Joseph H. Oved

Since Specialization
Citations

This map shows the geographic impact of Joseph H. Oved's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph H. Oved with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph H. Oved more than expected).

Fields of papers citing papers by Joseph H. Oved

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph H. Oved. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph H. Oved. The network helps show where Joseph H. Oved may publish in the future.

Co-authorship network of co-authors of Joseph H. Oved

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph H. Oved. A scholar is included among the top collaborators of Joseph H. Oved based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph H. Oved. Joseph H. Oved is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elgarten, Caitlin W., Joseph H. Oved, Lisa Wray, et al.. (2025). Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with Hemoglobinopathies. Transplantation and Cellular Therapy. 31(10). 828.e1–828.e14.
2.
Rocco, Joseph M., Elizabeth Laidlaw, Bonnie Yates, et al.. (2024). Proliferation of a Novel CD3neg Hyperactivated T-Cell Population Characterizes Adult Hemophagocytic Lymphohistiocytosis and Associates with Disease Activity. Blood. 144(Supplement 1). 5382–5382. 1 indexed citations
4.
6.
Oved, Joseph H., et al.. (2024). Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. Frontiers in Immunology. 15. 1369243–1369243.
7.
Laracy, Justin, Nina Cohen, Elizabeth Robilotti, et al.. (2023). Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients. Haematologica. 108(11). 3058–3067. 6 indexed citations
8.
Abraham, Allistair, Alice Bertaina, Senthil Velan Bhoopalan, et al.. (2023). International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant. Cytotherapy. 25(6). 578–589. 2 indexed citations
9.
Major-Monfried, Hannah, Neerav Shukla, Andromachi Scaradavou, et al.. (2023). Donor Derived Leukemia in a Recipient of Allogeneic Hematopoietic Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa. Transplantation and Cellular Therapy. 29(2). S367–S368.
11.
Behr, Gerald, et al.. (2023). Osteopetrorickets: two contradictory patterns—one unifying diagnosis. Skeletal Radiology. 53(4). 817–820.
12.
Fraint, Ellen, Elizabeth Klein, Audrey Mauguen, et al.. (2022). Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(1). 46.e1–46.e6. 5 indexed citations
13.
Oved, Joseph H., Andrew J. Paris, Kandace Gollomp, et al.. (2020). Neutrophils promote clearance of nuclear debris following acid-induced lung injury. Blood. 137(3). 392–397. 11 indexed citations
14.
Oved, Joseph H., Daria V. Babushok, Michele P. Lambert, et al.. (2020). Human mutational constraint as a tool to understand biology of rare and emerging bone marrow failure syndromes. Blood Advances. 4(20). 5232–5245. 7 indexed citations
15.
La, Ping, et al.. (2020). Mitochondria Biogenesis Modulates Iron–Sulfur Cluster Synthesis to Increase Cellular Iron Uptake. DNA and Cell Biology. 39(5). 756–765. 10 indexed citations
16.
Oved, Joseph H., Michele P. Lambert, M. Anna Kowalska, Mortimer Poncz, & Konrad J. Karczewski. (2020). Population based frequency of naturally occurring loss‐of‐function variants in genes associated with platelet disorders. Journal of Thrombosis and Haemostasis. 19(1). 248–254. 14 indexed citations
17.
Oved, Joseph H., et al.. (2019). Exceptional Response to Nivolumab in a 13-Year-Old Female with Metastatic HPV-Negative Cervical Carcinoma. DNA and Cell Biology. 38(10). 1143–1146.
18.
Wu, William E., Ivan I. Kirov, Assaf Tal, et al.. (2013). Brain MR spectroscopic abnormalities in “MRI-negative” tuberous sclerosis complex patients. Epilepsy & Behavior. 27(2). 319–325. 4 indexed citations
19.
Herrera, Raúl, Joseph H. Oved, & Carol Shoshkes Reiss. (2008). Disruption of IFN-γ–Mediated Antiviral Activity in Neurons: The Role of Cannabinoids. Viral Immunology. 21(2). 141–152. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026